Delivery Order SPE2DB20D9331-SPE2DB26FL0C8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,000.38 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of ZOSYN 3.375 GM/50 ML Galaxy 50ML. This firm fixed-price delivery order, issued on December 8, 2025, with an ultimate completion date of December 30, 2025, carries no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,486.40 contract is for the delivery of ZOSYN 4.5 GM/100 ML GALAXY BAG 100ML, a pharmaceutical product, with a performance period ending on July 9, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $1,659.50, is for the supply of pharmaceutical products such as ZOSYN 3.375 GM/50 ML GALAXY 50ML to support the recurring medical supply needs of military health facilities worldwide. This delivery order contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,036.00 to DMS Pharmaceutical Group Inc. on August 29, 2025, for the supply of Zosyn 4.5 GM/100 ML in Galaxy Bag format (100 ML units). This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $500 million single-award contract valid through November 2026 that authorizes the issuance of firm fixed-price delivery orders for comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,078.70 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of a pharmaceutical product, ZOSYN 4.5 GM/100 ML GALAXY BAG 100ML, to support the medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued...
- The Defense Logistics Agency awarded a $4,982.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Zosyn 4.5 GM/100 ML Galaxy Bag 100ML. The delivery order, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, a delivery order valued at $1,554.00 for ZOSYN 4.5 GM/100 ML Galaxy Bag 100ML on July 24, 2025. The contract utilizes firm fixed-price pricing with an ultimate completion date of August 14, 2025, and specifies Park Ridge, Illinois as the place of performance. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,315.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 16, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 7, 2025, covers the supply of ZOSYN 4.5 GM/100 ML in Galaxy bag format (100 ML units). The contract was issued without a set-aside designation, and performance will take place at the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,544.85 to DMS Pharmaceutical Group Inc. for the supply of Zosyn 4.5 GM/100 ML Galaxy Bag in 100 ML units. This delivery order, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, represents a firm fixed-price contract with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $1,078.70, is for the supply of a pharmaceutical product called ZOSYN 4.5 GM/100 ML GALAXY BAG 100ML. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB26FL0C8Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,036.00 to DMS Pharmaceutical Group Inc. for ZOSYN 4.5 GM/100 ML Galaxy Bag 100ML, with an ultimate completion date of November 19, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply support to Department of Defense healthcare facilities worldwide. The PPV-G GEN V contract awarded to DMS Pharmaceutical Group, designated SPE2DR, carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, structured as a 30-month base period with three 30-month option periods. Through this master contract vehicle, the DLA authorizes firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to support recurring medical supply needs across military healthcare operations globally. DMS Pharmaceutical Group's established performance on numerous delivery orders issued by the DLA's Medical Supply Chain division, ranging from under $100 to over $115,000, demonstrates the company's capability to fulfill the diverse and specialized pharmaceutical requirements of the federal military medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/28/25 |